Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
about
Cancer Stem and Progenitor-Like Cells as Pharmacological Targets in Breast Cancer Treatment11-Substituted Benzo[c]phenanthridines: New Structures and Insight into Their Mode of Antiproliferative Action.CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.EZH2 promotes colorectal cancer stem-like cell expansion by activating p21cip1-Wnt/β-catenin signaling.Dichloroacetate potentiates tamoxifen-induced cell death in breast cancer cells via downregulation of the epidermal growth factor receptor.Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro.Nanocarrier based approaches for targeting breast cancer stem cells.O-Linked N-Acetylglucosamine (O-GlcNAc) Expression Levels Epigenetically Regulate Colon Cancer Tumorigenesis by Affecting the Cancer Stem Cell Compartment via Modulating Expression of Transcriptional Factor MYBL1.Flubendazole inhibits glioma proliferation by G2/M cell cycle arrest and pro-apoptosis.
P2860
Q27024816-97387546-F473-49F6-B889-74EE01903034Q36108617-5188AB8C-31FA-4EB2-AB6E-B70522478629Q36562166-D0D4FC98-A554-4183-8904-743501756B38Q37520284-23E3E2B2-9671-49F8-902A-E477C7C04028Q37644942-60F66E87-D794-428D-8371-91816F9EB7EEQ37706533-D4BDA4F7-5355-4FDB-8EF6-84E16338A0AAQ38806553-6C8D14C7-6A73-4277-BC7B-C3218DC35318Q48209273-673CDC45-4EA2-460D-AB11-01A5AB807024Q51185635-F18EFA27-5B62-4843-8E87-0964DF5D3C28Q52659227-14124E2B-6608-42E1-B834-678B1FE961AF
P2860
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
@ast
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
@en
type
label
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
@ast
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
@en
prefLabel
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
@ast
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
@en
P2093
P2860
P356
P1433
P1476
Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells.
@en
P2093
Fei-Meng Zheng
Guo-Hui Li
Ling-Zhi Xu
Quentin Liu
P2860
P304
P356
10.18632/ONCOTARGET.3436
P407
P577
2015-03-01T00:00:00Z